 Panacea Life Sciences, Inc. - the renamed Exactus, Inc. - has said it plans to capitalize on Denver International Airports DEN popularity among travelers to market its Cannabidiol CBD products. Passenger traffic at Denver airport was the third-highest in the world during the first half of 2021 with nearly 25 million passengers, offering many opportunities for travelers to see, try, and buy Panaceas CBD products at its two kiosk locations in B and C concourses at the airport, the company said. 